Dr. Keith Anthony Bonacquisti, MD

Dr. Bonacquisti practices at Lake Regional Hospital in Osage Beach, Missouri, part of Lake Regional Health System.

Dr. Bonacquisti's NPI, 1487773669, was assigned on March 28, 2007. Dr. Bonacquisti holds Missouri license 109503.

Dr. Bonacquisti's primary practice is Lake Regional Hospital, at 54 Hospital Drive, Osage Beach, MO 65065 in Camden County. The practice phone is (573) 348-8000.

Dr. Bonacquisti's primary practice is Lake Regional Hospital in Osage Beach, Missouri, part of Lake Regional Health System. Dr. Bonacquisti is also affiliated with Baptist Medical Center South. The medical group on file is Montgomery Cardiovascular Associates, P.C. Dmand AI also links Dr. Bonacquisti to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bonacquisti practices, 6 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Bonacquisti's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dmand AI has Dr. Bonacquisti's licenses on file in 2 states: Missouri and Illinois.

CMS data shows 369 Medicare services from Dr. Bonacquisti across 8 procedure codes in 2024, for 202 Medicare patients. Medicare paid $17,776 for them. Every service was in an office.

CMS counts 202 Medicare patients who saw Dr. Bonacquisti in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bonacquisti's median patient age at 70, with 50% women.

In 2024, Dr. Bonacquisti wrote 903 Medicare Part D claims for 284 patients. 94% of them were for generic drugs. CMS names the drug for 814 of them, across 14 drugs with 11 or more claims each, at $131,899 in total drug cost. In 2023, CMS named 1,308 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Bonacquisti for performance year 2024, reported as part of a group. Dr. Bonacquisti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 116 general payments to Dr. Bonacquisti from 17 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 79% of the total. Medical Device Business Services, Inc. paid the most, $771.